IOVA
IOVANCE BIOTHERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$10.25
+2.30%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $109.1M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.11
- EPS estimate
- -$0.13
- Revenue actual
- $99.3M
- Revenue estimate
- $87.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +12.4%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $10
- PT range
- $7.00 – $15
- Analysts
- 5
4 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.13 | -$0.11 | Beat 17.58% | $99.3M |
| May 7, 2026 | -$0.19 | -$0.19 | In line | $71.4M |
| Feb 24, 2026 | -$0.22 | -$0.18 | Beat 18.18% | $86.8M |
| Nov 6, 2025 | -$0.29 | -$0.25 | Beat 13.79% | $67.5M |
| Aug 7, 2025 | -$0.29 | -$0.33 | Miss -13.79% | $60.0M |
| May 8, 2025 | -$0.25 | -$0.36 | Miss -44.00% | $49.3M |
| Feb 27, 2025 | -$0.26 | -$0.26 | In line | $73.7M |
| Nov 7, 2024 | -$0.31 | -$0.28 | Beat 9.68% | $58.6M |
| Aug 8, 2024 | -$0.37 | -$0.34 | Beat 8.11% | $31.1M |
| May 9, 2024 | -$0.45 | -$0.42 | Beat 6.67% | $715.0K |
| Feb 28, 2024 | -$0.44 | -$0.45 | Miss -2.27% | $482.0K |
| Feb 28, 2023 | -$0.64 | -$0.64 | In line | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026